OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip Read More
OraLiva empowers dental professionals across all practice types to offer clinically validated oral cancer screening. Each practice type has its own workflows and priorities. OraLiva adapts to fit them whether in general practice, a specialty clinic, or across a DSO network.
Detect oral cancer earlier with a painless, AI-powered brush biops, built for hygiene visits and easy to implement. Comfortable, fast, and fully reimbursable.
Unify your approach to cancer screening with one proven platform, making early detection efficient, reimbursable, and repeatable.
Join the OraLiva wait list for product launch news and insights designed to support your team and improve early cancer detection in everyday care.
Join OraLiva's Waitlist
